|
GRINL1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.408700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.680320E-02 |
| Normal-vs-Stage2 |
8.370000E-02 |
| Normal-vs-Stage3 |
1.72659999964075E-07 |
| Normal-vs-Stage4 |
1.17130000143462E-08 |
| Stage1-vs-Stage2 |
8.223800E-01 |
| Stage1-vs-Stage3 |
3.841300E-04 |
| Stage1-vs-Stage4 |
2.25179999999714E-05 |
| Stage2-vs-Stage3 |
8.581800E-02 |
| Stage2-vs-Stage4 |
4.021800E-02 |
| Stage3-vs-Stage4 |
5.649000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.820900E-04 |
| Normal-vs-AfricanAmerican |
3.6525000000065E-05 |
| Normal-vs-Asian |
6.990800E-01 |
| Caucasian-vs-AfricanAmerican |
1.607000E-01 |
| Caucasian-vs-Asian |
3.523400E-01 |
| AfricanAmerican-vs-Asian |
1.244560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.352900E-04 |
| Normal-vs-Female |
1.5951899999922E-05 |
| Male-vs-Female |
1.833180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.899000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.860100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.413400000014E-06 |
| Normal-vs-Age(81-100Yrs) |
3.004400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.666800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.590800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.175000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.976100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.295800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.183200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.238000E-01 |
| Normal-vs-Grade 2 |
1.376040E-02 |
| Normal-vs-Grade 3 |
3.43339999997472E-06 |
| Normal-vs-Grade 4 |
2.63480015583184E-10 |
| Grade 1-vs-Grade 2 |
8.204200E-01 |
| Grade 1-vs-Grade 3 |
2.015000E-01 |
| Grade 1-vs-Grade 4 |
5.160600E-03 |
| Grade 2-vs-Grade 3 |
1.275890E-02 |
| Grade 2-vs-Grade 4 |
6.59789999968297E-07 |
| Grade 3-vs-Grade 4 |
3.104300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.971700E-02 |
| Normal-vs-ccB subtype |
1.559750E-03 |
| ccA subtype-vs-ccB subtype |
2.412200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.119510E-03 |
| Normal-vs-N1 |
5.042700E-03 |
| N0-vs-N1 |
2.708400E-01 |
|
|
